MagnaMedics

company

About

MagnaMedics has established itself as a valued partner for routine.

  • 1 - 10

Details

Last Funding Type
Series B
Industries
Biotechnology,Nanotechnology,Project Management
Founded date
Jan 1, 2003
Number Of Employee
1 - 10
Operating Status
Active

MagnaMedics engineers and produces magnetic nano- and microparticles that are used in medical devices, drug delivery tools and diagnostic kits. Diagnostic kits are used for determination of biomarkers in body fluids; the company focuses on proteomics and more specifically on high-quantity isolation of proteins as well as on research customers active in high-throughput screening of biomarkers.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
MagnaMedics has raised a total of — in funding over 2 rounds. Their latest funding was raised on Feb 1, 2011 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 1, 2011 Series B 2 Detail
Jan 1, 2008 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
MagnaMedics is funded by 2 investors. BioScience Ventures Group and Limburg Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
BioScience Ventures Group Series B
Limburg Ventures Series B